51629
Hikma Finance USA LLC
Aug 19, 2025
Jordan
Middle East
Jun 30, 2025
B - Limited
Active
Aug 19, 2025
Regional Industry MAS MCT
other
Approved : Jun 30, 2025
Signed : Jul 3, 2025
Invested : Jul 10, 2025
Pharmaceuticals and Medicine Manufacturing
Hikma Pharmaceuticals PLC (“Hikma” or the “Company” or together with its subsidiaries “the Group”) is a pharmaceutical company incorporated in the United Kingdom (UK) and listed on the London Stock Exchange. While the Group was founded in Jordan in 1978, Hikma has expanded its footprint with successful operations across the Middle East and North Africa (MENA) region, North America and Europe with 29 manufacturing plants in 10 countries. Hikma is a long-standing IFC client since 1987 whereby support was primarily provided for the Company’s investments in the MENA region.
IFC provided a financing package (the “Financing Package”) to Hikma Finance USA LLC (the “Borrower”), a wholly owned subsidiary of Hikma. Proceeds of the IFC Loan (as defined below) and the Bond (as defined below) which, for the avoidance of doubt, is limited to IFC’s subscription of US$50 million in the Bond, will be used to support the Company’s general corporate purposes including acquisitions, capital expenditure, working capital needs, and any investment in research and development in the Middle East region, as well as debt refinancing of the Group (the “Project”).
N/A
For Inquiries About the Project, Contact
For Inquiries and Comments About IFC, Contact
Local Access of Project Documentation
Ibrahim Omari, Associate Director
+962 6 580 3100
iomari@hikma.com
Hikma HQ, MENA, Al-Bayader, King Abdullah The Second Street, Facing Al-Ahli Club, Amman, Jordan